Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444964 · ClinicalTrials.gov registry record · Phase 3
Growth Hormone Use in Adults With Prader-Willi Syndrome
A Phase 3 study of Prader-Willi Syndrome, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 3
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT00444964 is a Phase 3 study of Prader-Willi Syndrome that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 11 participants, below the 70-participant average among 16 other Prader-Willi Syndrome trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00444964, a Phase 3 study of Prader-Willi Syndrome, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The main research question this protocol aims to answer is whether treatment with growth hormone will impact body composition, quality of life, and energy balance in PWS adults, and if there is a loss of effects after cessation of treatment for at least 12 months.
Conditions Studied
Interventions
- DRUG Nutropin AQ
Study Locations (1)
Missouri
- The Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2005-04 |
| Est. Completion | 2012-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444964
The ClinicalTrials.gov registry entry for NCT00444964 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 70-participant average among 16 other Prader-Willi Syndrome trials with a reported enrollment target (84% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prader-Willi Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Nutropin AQ is the first listed.
NCT00444964 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00444964 about?
NCT00444964 is a clinical study titled "Growth Hormone Use in Adults With Prader-Willi Syndrome". The main research question this protocol aims to answer is whether treatment with growth hormone will impact body composition, quality of life, and energy balance in PWS adults, and if there is a loss of effects after cessation of treatment for at least 12 months.
What is the current status of trial NCT00444964?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 11 participants. The study started on 2005-04. Estimated completion is 2012-01-01.
What conditions does trial NCT00444964 study?
This clinical trial studies the following conditions: Prader-Willi Syndrome.
What interventions are being tested in trial NCT00444964?
The interventions under investigation include: Nutropin AQ (DRUG).
Who is sponsoring clinical trial NCT00444964?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00444964 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prader-Willi Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS
RECRUITING · Phase 3
-
A Study of Pitolisant in Patients With Prader-Willi Syndrome
RECRUITING · Phase 3
-
Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
ACTIVE NOT RECRUITING · Phase 3
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
RECRUITING · Phase 1
-
Cerebellar TMS and Satiety in Prader-Willi Syndrome
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.